CLINICAL_TRIALS
trial_result
· 2020-03-27
Clinical Trial Update: MK-8189 Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) [Phase 1]
Summary
Phase 1 clinical trial update for MK-8189 in healthy volunteers and schizophrenia participants; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2020-03-27